198 related articles for article (PubMed ID: 6244418)
1. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
Lucas VS; Laszlo J
JAMA; 1980 Mar; 243(12):1241-3. PubMed ID: 6244418
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
[TBL] [Abstract][Full Text] [Related]
3. delta 9-tetrahydrocannabinol in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
JAMA; 1981 May 22-29; 245(20):2047-51. PubMed ID: 6262541
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
Orr LE; McKernan JF
J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
[TBL] [Abstract][Full Text] [Related]
5. The California program for the investigational use of THC and marihuana in heterogeneous populations experiencing nausea and vomiting from anticancer therapy.
Dow GJ; Meyers FH
J Clin Pharmacol; 1981; 21(S1):128S-132S. PubMed ID: 6271818
[TBL] [Abstract][Full Text] [Related]
6. delta 9-Tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A pilot study.
Sweet DL; Miller NJ; Weddington W; Senay E; Sushelsky L
J Clin Pharmacol; 1981; 21(S1):70S-75S. PubMed ID: 6271845
[TBL] [Abstract][Full Text] [Related]
7. Stress inoculation training in the control of THC toxicities.
Roffman RA
Int J Addict; 1986 Aug; 21(8):883-96. PubMed ID: 3021638
[TBL] [Abstract][Full Text] [Related]
8. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
Lane M; Vogel CL; Ferguson J; Krasnow S; Saiers JL; Hamm J; Salva K; Wiernik PH; Holroyde CP; Hammill S
J Pain Symptom Manage; 1991 Aug; 6(6):352-9. PubMed ID: 1652611
[TBL] [Abstract][Full Text] [Related]
9. delta 9-Tetrahydrocannabinol and therapeutic research legislation for cancer patients.
Treffert DA; Joranson DE
JAMA; 1983 Mar; 249(11):1469-72. PubMed ID: 6298477
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic issues of marijuana and THC (tetrahydrocannabinol).
Ungerleider JT; Andrysiak T
Int J Addict; 1985 May; 20(5):691-9. PubMed ID: 2995262
[TBL] [Abstract][Full Text] [Related]
11. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
Lane M; Smith FE; Sullivan RA; Plasse TF
Am J Clin Oncol; 1990 Dec; 13(6):480-4. PubMed ID: 2173391
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
Orr LE; McKernan JF; Bloome B
Arch Intern Med; 1980 Nov; 140(11):1431-3. PubMed ID: 6254456
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in the management of severe nausea and vomiting from cancer chemotherapy. Some additional considerations.
Garb S
J Clin Pharmacol; 1981; 21(S1):57S-59S. PubMed ID: 6271843
[TBL] [Abstract][Full Text] [Related]
15. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
Einhorn L
Cancer Treat Rev; 1982 Dec; 9 Suppl B():55-61. PubMed ID: 6299557
[No Abstract] [Full Text] [Related]
16. Recent clinical experience with dronabinol.
Plasse TF; Gorter RW; Krasnow SH; Lane M; Shepard KV; Wadleigh RG
Pharmacol Biochem Behav; 1991 Nov; 40(3):695-700. PubMed ID: 1666930
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
McCabe M; Smith FP; Macdonald JS; Woolley PV; Goldberg D; Schein PS
Invest New Drugs; 1988 Sep; 6(3):243-6. PubMed ID: 2847994
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials with antiemetic agents in cancer patients receiving chemotherapy.
Penta JS; Poster DS; Bruno S; Macdonald JS
J Clin Pharmacol; 1981; 21(S1):11S-22S. PubMed ID: 6271815
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Rosenberg SA
Cancer; 1981 Apr; 47(7):1746-51. PubMed ID: 6261926
[TBL] [Abstract][Full Text] [Related]
20. Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis.
Hernandez SL; Sheyner I; Stover KT; Stewart JT
Am J Hosp Palliat Care; 2015 Feb; 32(1):5-7. PubMed ID: 24052427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
